" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "
NCT06983756 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2025-05-21
Summary
The primary aim of this study is to investigate the association between metabolic syndrome and erythropoietin resistance in patients with End-Stage Kidney Disease (ESKD).
Conditions
- Erythropoietin Resistant Anemia (EPO Resistant Anemia)
Interventions
- DRUG
-
Erythropoietin
EPO resistance
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-01
- Primary Completion
- 2025-12-01
- Completion
- 2026-01-01
More Related Trials
-
A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)
NCT00924781 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital
NCT06053866 ·Status: NOT_YET_RECRUITING
-
A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
NCT00576602 ·Status: TERMINATED ·Phase: PHASE4
-
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
NCT01587924 ·Status: COMPLETED ·Phase: PHASE2
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
Renal Anemia Refractory to Erythropoietin
NCT03480178 ·Status: UNKNOWN
-
Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
NCT01977482 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Study of Pentoxifylline for the Treatment of Anemia
NCT01102218 ·Status: TERMINATED ·Phase: PHASE2
-
The Clinical Evaluation of the Dose of Erythropoietins Trial
NCT00827021 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)
NCT00968617 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
NCT02075463 ·Status: TERMINATED ·Phase: PHASE2
-
Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy
NCT02860598 ·Status: UNKNOWN
-
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
NCT02586402 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
NCT02299661 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
NCT00563355 ·Status: COMPLETED ·Phase: NA
-
Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT03950687 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT04231292 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia
NCT05691257 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients
NCT04134026 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Pentoxifylline on Anemia in Hemodialysis Patients
NCT05708248 ·Status: UNKNOWN ·Phase: NA
-
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
NCT00701714 ·Status: TERMINATED ·Phase: PHASE3
-
Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant
NCT01555515 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Sustained Erythropoietin Therapy
NCT00542568 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis
NCT02366325 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS
NCT04573686 ·Status: UNKNOWN